Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity

International Journal of Obesity volume 34, pages 687–700 (2010)Cite this article

Subjects

Abstract

Objective:

Circulating endothelial progenitor cells (EPCs), responsible for neoangiogenesis and vascular repair, negatively correlate with vascular dysfunction and atherosclerotic risk factors. Because obesity may have a crucial role in the development of endothelial dysfunction, this study evaluated the number and proliferative activity of circulating human EPCs in obese (body mass index (BMI)=48±9, n=45) compared with lean (23±2, n=45) volunteers.

Methods:

EPCs were quantified after isolation of peripheral blood mononuclear cells (PBMCs) using fluorescence-activated cell sorting analyses. In addition, plated PBMCs developed colony-forming units (CFUs) from which ‘outgrowth’ endothelial cells (OECs) sprouted and differentiated into mature endothelial cells. Growth rates were monitored by periodical microscopic evaluation. Cell-cycle protein expression was determined by western blot analyses.

Results:

BMI negatively correlated (P<0.01) with the number of CD34+/CD133+/KDR+ (r=−0.442), CD34+/KDR+ (r=−0.500) and CD133+/KDR+ (r=−0.282) EPCs. Insulin, leptin, HbA1c, high-sensitivity C-reactive protein and hypertension, as well as diminished high-density lipoprotein and apolipoprotein A1, were not only associated with obesity but also with significantly reduced EPC levels. Applying selective culture conditions, EPC–CFUs differentiated into OECs that proliferated more slowly when derived from obese compared with lean subjects (obese: 19.9±2.2% vs lean: 30.9±3.2% grown area per week, P<0.01). The reduced proliferation was reflected by decreased (P<0.05, n=24 for each group) expression of cell-cycle-promoting cyclins and E2F-1, by hypophosphorylation of retinoblastoma protein and by increased (P<0.05, n=24 for each group) expression of the cell-cycle inhibitor p21WAF−1/Cip1.

Conclusions:

Reduced numbers of EPCs along with their premature senescence, as shown in this study, could function as early contributors to the development and progression of vascular dysfunction in obesity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM . Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006; 295: 1549–1555.

    Article  CAS  Google Scholar 

  2. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW . Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 2009; 335: 165–189.

    Article  CAS  Google Scholar 

  3. Jonk AM, Houben AJ, de Jongh RT, Serné EH, Schaper NC, Stehouwer CD . Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda) 2007; 22: 252–260.

    CAS  Google Scholar 

  4. Meyers MR, Gokce N . Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2007; 14: 365–369.

    Article  CAS  Google Scholar 

  5. Artwohl M, Lindenmair A, Sexl V, Maier C, Rainer G, Freudenthaler A et al. Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells. J Lipid Res 2008; 49: 2627–2640.

    Article  CAS  Google Scholar 

  6. Artwoh M, Graier WF, Roden M, Bischof M, Freudenthaler A, Waldhäusl W et al. Diabetic LDL triggers apoptosis in vascular endothelial cells. Diabetes 2003; 52: 1240–1247.

    Article  Google Scholar 

  7. Dimmeler S, Zeiher AM . Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 2004; 82: 671–677.

    Article  Google Scholar 

  8. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.

    Article  CAS  Google Scholar 

  9. Maeng YS, Choi HJ, Kwon JY, Park YW, Choi KS, Min JK et al. Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC(beta)2 axis. Blood 2009; 113: 233–243.

    Article  CAS  Google Scholar 

  10. Fadini GP, Agostini C, Sartore S, Avogaro A . Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007; 194: 46–54.

    Article  Google Scholar 

  11. Cubbon RM, Rajwani A, Wheatcroft SB . The impact of insulin resistance on endothelial function, progenitor cells and repair. Diab Vasc Dis Res 2007; 4: 103–111.

    Article  Google Scholar 

  12. Westerweel PE, Visseren FL, Hajer GR, Olijhoek JK, Hoefer IE, de Bree P et al. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs simvastatin/ezetimibe combination therapy. Eur Heart J 2008; 29: 2808–2817.

    Article  CAS  Google Scholar 

  13. Müller-Ehmsen J, Braun D, Schneider T, Pfister R, Worm N, Wielckens K et al. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur Heart J 2008; 29: 1560–1568.

    Article  Google Scholar 

  14. MacEneaney OJ, Kushner EJ, Van Guilder GP, Greiner JJ, Stauffer BL, DeSouza CA . Endothelial progenitor cell number and colony-forming capacity in overweight and obese adults. Int J Obes (London) 2009; 33: 219–225.

    Article  CAS  Google Scholar 

  15. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449–1457.

    Article  CAS  Google Scholar 

  16. Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A et al. Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 2007; 50: 2156–2163.

    Article  CAS  Google Scholar 

  17. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1–E7.

    Article  CAS  Google Scholar 

  18. Wang HY, Gao PJ, Ji KD, Shen WF, Fan CL, Lu L et al. Circulating endothelial progenitor cells, C-reactive protein and severity of coronary stenosis in Chinese patients with coronary artery disease. Hypertens Res 2007; 30: 133–141.

    Article  CAS  Google Scholar 

  19. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981–2987.

    Article  Google Scholar 

  20. Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC et al. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am Heart J 2006; 152: 1051.e1-8.

    Article  Google Scholar 

  21. Bamba V, Rader DJ . Obesity and atherogenic dyslipidemia. Gastroenterology 2007; 132: 2181–2190.

    Article  CAS  Google Scholar 

  22. Van Craenenbroeck EM, Vrints CJ, Haine SE, Vermeulen K, Goovaerts I, Van Tendeloo VF et al. A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile. J Appl Physiol 2008; 104: 1006–1013.

    Article  CAS  Google Scholar 

  23. Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M et al. Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 278–283.

    Article  CAS  Google Scholar 

  24. Ciulla MM, Giorgetti A, Silvestris I, Cortiana M, Montelatici E, Paliotti R et al. Endothelial colony forming capacity is related to C-reactive protein levels in healthy subjects. Curr Neurovasc Res 2006; 3: 99–106.

    Article  CAS  Google Scholar 

  25. Pellegatta F, Bragheri M, Grigore L, Raselli S, Maggi FM, Brambilla C et al. In vitro isolation of circulating endothelial progenitor cells is related to the high density lipoprotein plasma levels. Int J Mol Med 2006; 17: 203–208.

    CAS  PubMed  Google Scholar 

  26. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis—results from a large population-based study. PLoS ONE 2007; 2: e975.

    Article  Google Scholar 

  27. Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH . Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (London) 2004; 107: 273–280.

    Article  CAS  Google Scholar 

  28. Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B et al. High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 2007; 192: 92–99.

    Article  CAS  Google Scholar 

  29. Delva P, Degan M, Vallerio P, Arosio E, Minuz P, Amen G et al. Endothelial progenitor cells in patients with essential hypertension. J Hypertens 2007; 25: 127–132.

    Article  CAS  Google Scholar 

  30. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A . Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008; 197: 496–503.

    Article  CAS  Google Scholar 

  31. George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A . Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 2006; 12: 331–335.

    Article  CAS  Google Scholar 

  32. DeGregori J, Kowalik T, Nevins JR . Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 1995; 15: 4215–4224.

    Article  CAS  Google Scholar 

  33. Dotto GP . p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000; 1471: M43–M56.

    CAS  PubMed  Google Scholar 

  34. Nevins JR . E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258: 424–429.

    Article  CAS  Google Scholar 

  35. Stein GH, Drullinger LF, Soulard A, Dulić V . Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999; 19: 2109–2117.

    Article  CAS  Google Scholar 

  36. Sugawara J, Mitsui-Saito M, Hayashi C, Hoshiai T, Senoo M, Chisaka H et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 2005; 90: 5329–5332.

    Article  CAS  Google Scholar 

  37. Imanishi T, Moriwaki C, Hano T, Nishio I . Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23: 1831–1837.

    Article  CAS  Google Scholar 

  38. Pu DR, Liu L . HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL. Med Hypotheses 2008; 70: 338–342.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Magdalena Reithner for excellent technical assistance. This study was supported by the Karl Landsteiner Institute for Endocrinology and Metabolism.

Author information

Authors and Affiliations

  1. Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria

    K Tobler, A Freudenthaler, S M Baumgartner-Parzer, M Wolzt, B Ludvik, E Nansalmaa, P J Nowotny, A Luger & M Artwohl

  2. Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

    M Wolzt

  3. School of Biomedicine, Health Science University, Ulaanbaatar, Mongolia

    E Nansalmaa

  4. Department of Internal Medicine II, Clinical Division of Angiology, Medical University of Vienna, Vienna, Austria

    D Seidinger & S Steiner

  5. Karl Landsteiner Institute for Endocrinology and Metabolism, Hanusch Hospital Vienna, Vienna, Austria

    M Artwohl

Authors
  1. K Tobler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Freudenthaler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S M Baumgartner-Parzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Wolzt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Ludvik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E Nansalmaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P J Nowotny
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D Seidinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Luger
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M Artwohl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Artwohl.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tobler, K., Freudenthaler, A., Baumgartner-Parzer, S. et al. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes 34, 687–700 (2010). https://doi.org/10.1038/ijo.2009.280

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2009.280

Keywords

This article is cited by

Search

Advanced search

Quick links